Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions

Over the past year, substantial global efforts have been made to connect the signs, symptoms, and consequences of the SARS-CoV-2 virus (COVID-19). Among the associated sequel includes the noted higher incidence of cardiac arrhythmias [1]. A relationship is unfolding between this widespread virus, underlying cardiovascular disease (CVD) and new onset arrhythmias [1-3]. As these complications are associated with higher mortality rates and the number one cause of death in the US is CVD, it is crucial to develop proactive measures for at-risk patients [4].
Source: The American Journal of Emergency Medicine - Category: Emergency Medicine Authors: Source Type: research